Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Gillen

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Biometrical Journal. Biometrische Zeitschrift|December 29, 2025
A Covariance-Based Penalty Estimator for Model Assessment With Censored DataZhuoran Zhang, Daniel L Gillen
Statistics in Medicine|October 26, 2020
Robust estimation in the nested case-control design under a misspecified covariate functional formMichelle M Nuño, Daniel L Gillen
Biometrics|December 19, 2025
Censoring-robust estimation in fixed sample time-to-event clinical trials with adaptive randomizationNavneet R Hakhu, Daniel L Gillen
The Journal of Prevention of Alzheimer'S Disease|June 13, 2026
Eligibility of men vs. women in Alzheimer's trials: Inclusive vs. representativeJoshua D Grill, Daniel L Gillen
Statistics in Biosciences|March 20, 2020
Censoring-robust estimation in observational survival studies: Assessing the relative effectiveness of vascular access type on patency among end-stage renal disease patientsVinh Q Nguyen, Daniel L Gillen
Biometrics|July 14, 2005
A note on P-values under group sequential testing and nonproportional hazardsDaniel L Gillen, Scott S Emerson
Sequential Analysis|September 11, 2019
Flexibly Monitoring Group Sequential Survival Trials When Testing is Based Upon a Weighted Log-Rank StatisticSean S Brummel, Daniel L Gillen
Open Journal of Statistics|December 26, 2014
On the Use of Local Assessments for Monitoring Centrally Reviewed Endpoints with Missing Data in Clinical TrialsSean S Brummel, Daniel L Gillen
Statistics in Medicine|October 18, 2021
Censoring-robust time-dependent receiver operating characteristic curve estimatorsMichelle M Nuño, Daniel L Gillen
Lifetime Data Analysis|July 20, 2012
Robust inference in discrete hazard models for randomized clinical trialsVinh Q Nguyen, Daniel L Gillen
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Biometrical Journal. Biometrische Zeitschrift|December 29, 2025
A Covariance-Based Penalty Estimator for Model Assessment With Censored DataZhuoran Zhang, Daniel L Gillen
Statistics in Medicine|October 26, 2020
Robust estimation in the nested case-control design under a misspecified covariate functional formMichelle M Nuño, Daniel L Gillen
Biometrics|December 19, 2025
Censoring-robust estimation in fixed sample time-to-event clinical trials with adaptive randomizationNavneet R Hakhu, Daniel L Gillen
The Journal of Prevention of Alzheimer'S Disease|June 13, 2026
Eligibility of men vs. women in Alzheimer's trials: Inclusive vs. representativeJoshua D Grill, Daniel L Gillen
Statistics in Biosciences|March 20, 2020
Censoring-robust estimation in observational survival studies: Assessing the relative effectiveness of vascular access type on patency among end-stage renal disease patientsVinh Q Nguyen, Daniel L Gillen
Biometrics|July 14, 2005
A note on P-values under group sequential testing and nonproportional hazardsDaniel L Gillen, Scott S Emerson
Sequential Analysis|September 11, 2019
Flexibly Monitoring Group Sequential Survival Trials When Testing is Based Upon a Weighted Log-Rank StatisticSean S Brummel, Daniel L Gillen
Open Journal of Statistics|December 26, 2014
On the Use of Local Assessments for Monitoring Centrally Reviewed Endpoints with Missing Data in Clinical TrialsSean S Brummel, Daniel L Gillen
Statistics in Medicine|October 18, 2021
Censoring-robust time-dependent receiver operating characteristic curve estimatorsMichelle M Nuño, Daniel L Gillen
Lifetime Data Analysis|July 20, 2012
Robust inference in discrete hazard models for randomized clinical trialsVinh Q Nguyen, Daniel L Gillen
Pageof 16